Coagulation laboratory tests
Reviewer: Jeremy Parsons, M.D. (see Reviewers page)
Revised: 10 February 2013, last major update November 2012
Copyright: (c) 2002-2013, PathologyOutlines.com, Inc.
● Indications: patients with familial venous thrombosis but no evidence of other hypercoagulable states, occasionally used to monitor thrombolytic therapy or for patients with ligneous conjunctivitis
● Either functional (based on plasmin activity, Haemostasis 1988;18 Suppl 1:47) or immunologic (based on concentration of plasminogen antigen)
● Determine plasmin enzyme activity with plasmin-specific chromogenic substrate
● Add streptokinase to patient plasma, complex cleaves a chromogen releasing a colored compound
● Color is measured spectrophotometrically and is proportional to plasminogen in sample
● Expressed as percentage of normal plasma (reference range 75-130%)
● Radial immunodiffusion methods
● Used if dysplasminogenemia is being evaluated
● Ratio of functional activity to antigen is significantly decreased compared to controls
● Plasminogen levels are increased by oral contraceptives (which increase cholesterol levels), pregnancy and acute phase reactants
● Plasminogen levels are decreased by liver disease, thrombolytic therapy and DIC; newborns have levels that are 60% of adults, increase to adult values by age 6 months
End of Coagulation > Coagulation laboratory tests > Plasminogen assay
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).